Spider Capital
VC Fund
San Francisco, United States
Spider Capital is a seed-stage enterprise venture capital focused on the digital transformation of industry.
- Total investments:
- 88
- Last investment:
- Lead investor:
- 25%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Spider Capital invests in
Stages Spider Capital invests in
Countries Spider Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 8 contacts → | |||
Round size
- Seed
- $1.5M–$7M
- Series A
- $7M–$19M
- Series B
- $5.2M–$45M
Investment Focus
Industry
- Software 29 (33%)
- Artificial Intelligence 24 (27%)
- SaaS 15 (17%)
- Machine Learning 9 (10%)
- Enterprise Software 7 (8%)
Stage
- Seed 31 (35%)
- Series A 28 (32%)
- Series B 9 (10%)
- Venture - Series Unknown 9 (10%)
- Series C 2 (2%)
Country
- United States 37 (42%)
- Canada 4 (5%)
- Israel 3 (3%)
- United Kingdom 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
David Berman
Operating Partner
|
Operating Partner | Total investments: 0 | Find email | |
Courtney Broadus
Venture Partner
|
Venture Partner | Total investments: 17 | Find email | |
Judy Loehr
Operating Partner
|
Operating Partner | Total investments: 1 | Find email | |
Matt Fisher
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
Michael Neril
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 42 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Soteris provides artificial intelligence-based pricing tools to the insurance business. The company is working hard to transform the entire insurance value chain and would like to keep you updated on developments. | $8M / Seed / Sep 22, 2026 | ||
| Sylvan Labs is a software company that turns post-sales data into actionable growth opportunities for B2B teams. | $10.9M / Venture - Series Unknown / Sep 02, 2026 | ||
| Arintra provides an AI-powered autonomous medical coding platform to streamline hospital and clinic revenue cycle management. The platform processes clinical documentation to generate accurate diagnostic and procedural codes (e.g., ICD‑10, CPT) within electronic health records like Epic or Cerner, requiring zero manual input. It offers explainableaudit trails and analytics dashboards that track coding accuracy, denial trends, and workflow efficiency. Clients report measurable improvements such as a 5% increase in revenue and over 50% reduction in aged accounts receivable days following implementation. | $25M / Series B / Aug 21, 2026 | ||
| Cimba.AI, the Gen-AI-native platform that gives enterprises the power to create custom adaptive AI agents that can produce deep insights and recommend and trigger business actions based on internal data and knowledge base. The platform leverages self-training artificial intelligence that learns and adapts to an organization’s unique knowledgebase(i.e., dashboards, query history, metadata, playbooks, etc.), providing business decision makers with customizable AI agents that generate both insights and recommended next steps (i.e., which ten deals we should focus on this week?) to take based on their data (i.e., Snowflake) | $3M / Seed / Jan 19, 2026 | ||
| CoLab is a Design Engagement System that helps engineering teams make better technical decisions, faster. By combining AI-powered design checks with real-time collaboration, CoLab turns every review into structured, searchable knowledge database. Over time, that knowledge becomes fuel for AI agents that prevent repeat mistakes and surface lessonslearned when they matter most. It’s how engineering teams scale good decisions across people, programs, and time. | $17.2M / Secondary Market / Nov 10, 2025 | ||
| CoLab is a Design Engagement System that helps engineering teams make better technical decisions, faster. By combining AI-powered design checks with real-time collaboration, CoLab turns every review into structured, searchable knowledge database. Over time, that knowledge becomes fuel for AI agents that prevent repeat mistakes and surface lessonslearned when they matter most. It’s how engineering teams scale good decisions across people, programs, and time. | $72M / Series C / Nov 10, 2025 | ||
| Arintra provides an AI-powered autonomous medical coding platform to streamline hospital and clinic revenue cycle management. The platform processes clinical documentation to generate accurate diagnostic and procedural codes (e.g., ICD‑10, CPT) within electronic health records like Epic or Cerner, requiring zero manual input. It offers explainableaudit trails and analytics dashboards that track coding accuracy, denial trends, and workflow efficiency. Clients report measurable improvements such as a 5% increase in revenue and over 50% reduction in aged accounts receivable days following implementation. | $21M / Series A / Aug 14, 2025 | ||
| Our mission is to make preventing financial crime easy and effective.Risk data like sanctions, politically exposed persons and export controls are publicly available, but not in one place, language and data architecture. Clients are tired of cobbling together multiple vendors to get one source of truth. To solve this problem, Castellum.AI builtthe world’s most accurate, reliable and fastest compliance solution. Don't take our word for it, try our platform for free at www.castellum.ai. | $8.5M / Series A / Jul 08, 2025 | ||
| Mechanical Orchard is an AI-native technology company that de-risks the process of bringing old but critical computer systems up to date. We modernize and run crucial business applications used by some of the largest companies around the world. Our goal? Help our customers stay ahead of the curve, compete at an ever-accelerating pace, and win intheir markets. Mechanical Orchard is based in San Francisco, CA. | $24M / Series A / Feb 07, 2024 | ||
| Our mission is to make preventing financial crime easy and effective.Risk data like sanctions, politically exposed persons and export controls are publicly available, but not in one place, language and data architecture. Clients are tired of cobbling together multiple vendors to get one source of truth. To solve this problem, Castellum.AI builtthe world’s most accurate, reliable and fastest compliance solution. Don't take our word for it, try our platform for free at www.castellum.ai. | $4.2M / Seed / Oct 25, 2023 | ||
| See all 88 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Spider Capital invest in?
Spider Capital invests primarily in Software, Artificial Intelligence and SaaS startups, most often at Seed and Series A stage. Most of the 88 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Spider Capital's check size?
Spider Capital typically joins rounds of $1.5M–$7M at Seed, $7M–$19M at Series A and $5.2M–$45M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Spider Capital participates in.
How do I contact Spider Capital?
Public channels for Spider Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Spider Capital?
The team at Spider Capital includes David Berman (Operating Partner), Courtney Broadus (Venture Partner) and Judy Loehr (Operating Partner), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
